Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by porksnifferon Feb 28, 2019 9:04am

154 Views

Post# 29422020

RE:2nd Largest Shareholder calls for Substantial change

MJN7979 wrote: https://globenewswire.com/news-release/2019/02/28/1744286/0/en/Second-Largest-Knight-Therapeutics-Shareholder-Calls-for-Substantial-Change.html

There you go, what a surprise. I've been calling this turkey out for 2 years and got called all sorts of names on this pathetic forum, "shut up this is for your grandkids'. My asss. Now we know why this turd is trading at 3 year lows while 'dead' companies like BHC and ENDP gave trippled. Not surprising when the CEO equires his Blackberry to remember badic things (source Globe and Mail). JRG should do the honourable thing and just resign.

Bullboard Posts

Silvercorp to expand into Ecuador with C$200M Adventus acquisition